India
· Delayed Price · Currency is INR Amrutanjan Health Care Statistics
Total Valuation
Amrutanjan Health Care has a market cap or net worth of INR 20.18 billion. The enterprise value is 17.91 billion.
| Market Cap | 20.18B |
| Enterprise Value | 17.91B |
Important Dates
The last earnings date was Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | Nov 22, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.72% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 12.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.20, with an EV/FCF ratio of 98.72.
| EV / Earnings | 37.68 |
| EV / Sales | 4.09 |
| EV / EBITDA | 32.20 |
| EV / EBIT | 35.74 |
| EV / FCF | 98.72 |
Financial Position
The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.05 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.12 |
| Interest Coverage | 224.57 |
Financial Efficiency
Return on equity (ROE) is 16.98% and return on invested capital (ROIC) is 11.13%.
| Return on Equity (ROE) | 16.98% |
| Return on Assets (ROA) | 8.49% |
| Return on Capital (ROIC) | 11.13% |
| Revenue Per Employee | 6.91M |
| Profits Per Employee | 749,522 |
| Employee Count | 634 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 7.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.83% in the last 52 weeks. The beta is 0.76, so Amrutanjan Health Care's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +14.83% |
| 50-Day Moving Average | 752.87 |
| 200-Day Moving Average | 725.21 |
| Relative Strength Index (RSI) | 42.30 |
| Average Volume (20 Days) | 33,515 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amrutanjan Health Care had revenue of INR 4.38 billion and earned 475.20 million in profits. Earnings per share was 16.42.
| Revenue | 4.38B |
| Gross Profit | 2.14B |
| Operating Income | 501.02M |
| Pretax Income | 656.00M |
| Net Income | 475.20M |
| EBITDA | 551.82M |
| EBIT | 501.02M |
| Earnings Per Share (EPS) | 16.42 |
Balance Sheet
The company has 2.29 billion in cash and 22.14 million in debt, giving a net cash position of 2.27 billion.
| Cash & Cash Equivalents | 2.29B |
| Total Debt | 22.14M |
| Net Cash | 2.27B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.98B |
| Book Value Per Share | 103.00 |
| Working Capital | 2.30B |
Cash Flow
In the last 12 months, operating cash flow was 249.46 million and capital expenditures -68.08 million, giving a free cash flow of 181.38 million.
| Operating Cash Flow | 249.46M |
| Capital Expenditures | -68.08M |
| Free Cash Flow | 181.38M |
| FCF Per Share | n/a |
Margins
Gross margin is 48.86%, with operating and profit margins of 11.44% and 10.85%.
| Gross Margin | 48.86% |
| Operating Margin | 11.44% |
| Pretax Margin | 14.98% |
| Profit Margin | 10.85% |
| EBITDA Margin | 12.60% |
| EBIT Margin | 11.44% |
| FCF Margin | 4.14% |
Dividends & Yields
Amrutanjan Health Care does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | -21.74% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 28.17% |
| Buyback Yield | 0.72% |
| Shareholder Yield | 0.72% |
| Earnings Yield | 2.35% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on April 13, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Apr 13, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |